Newborn screening platform for lysosomal storage disorders with FDA clearance and CE mark.

SEEKER is a high throughput laboratory solution that quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens. Reduced activity of these enzymes may be indicative of Mucopolysaccharidosis Type I (MPS I), Pompe, Gaucher or Fabry disease.

Everything your lab needs for LSD screening in one small workstation.

False Positive Rates: SEEKER vs. NeoLSD

SEEKER was the first FDA-cleared product for newborn screening of lysosomal storage disorders (LSDs) in February 2017. Now that a second product NeoLSD has received clearance, a true clinical data comparison can be made from the 510(k) submissions. The results? NeoLSD’s false positive rates are roughly double those of SEEKER.

SEEKER Brochure

DOWNLOAD THE BROCHURE

Workflow in Action

WATCH THE VIDEO

“FDA clearance enables state laboratories to confidently implement testing while minimizing the validation effort resulting in a cost effective implementation.”

Lab Products Advisory Board

Rodney is Professor of Pediatrics and Chair Emeritus of the Department of Pediatrics at the University of Miami School of Medicine. He is Board Certified in Pediatrics as well certified as by the American Board of Medical Genetics in the area of Human Biochemical Genetics. He was the founding chair of the Secretary’s Advisory Committee of Heritable Disorders in Newborns and Children (SACHDNC), an eight-year effort to establish the US Department of Health and Human Services’ national screening guidelines in 2010, including the addition of many genetic and metabolic conditions to the core newborn screening panel. Rodney is the author of more than 150 papers dealing with genetic-metabolic diseases in childhood. He served as Senior Advisor to the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health in Bethesda, MD (2004-2011). During this time, he oversaw some of the NICHD research initiatives in newborn screening. He served as President of the American College of Medical Genetics and has advised and led research on numerous efforts related to genetics, children’s issues and newborn screening. He is a graduate of Davidson College and the Duke University School of Medicine, where he was trained in Pediatrics and Genetics.